ARTG 330213Lubricant, eye
ARTG ID: 330213 · AFT Pharmaceuticals Pty Ltd · Novaliq GmbH · Class IIa · Started February 20, 2020
Good Name: AFT Pharmaceuticals Pty Ltd - Lubricant, eye
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 330213
- Start Date
- February 20, 2020
- Effective Date
- February 20, 2020
- Name
- Novaliq GmbH
- Country
- Germany
- Address
- Im Neuenheimer Feld 515, Heidelberg, 69120
NovaTears®+Omega-3 stabilizes the lipid layer of the tear film and reduces the evaporation of the underlying water phase of the tear film. NovaTears®+Omega-3 lubricates and protects the corneal surface and thereby relieves the symptoms associated with Dry Eye like burning, itching, stinging and foreign body sensation.
Access comprehensive regulatory information for Lubricant, eye in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 330213 and sponsored by AFT Pharmaceuticals Pty Ltd, manufactured by Novaliq GmbH in Germany. The device registration started on February 20, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.